The University of Á¢²©¹ÙÍø researchers and start-ups have won 4 out of 6 awards at the prestigious .
won Company of the Year for its development of the innovative High-Density Microarray Patch, a needle-free vaccine delivery platform. The technology has the potential to transform vaccine delivery globally and strengthen Á¢²©¹ÙÍø’s position as a leader in biotechnology.
Another UniQuest start-up received the LSQ Radium Capital Emerging Innovator Award, in recognition of their work to develop new vaccines for life-threatening respiratory viral infectious diseases using UQ’s Molecular Clamp platform.
UQ Vice-Chancellor Professor Deborah Terry said the result highlights the significant impact of the commercially relevant research being undertaken at the University.
“The success of these start-ups, build on UQ innovation, is a great demonstration of research and innovation, from discovery through to translation, to solve key health challenges,” she said.
“Bringing these technologies and products to market also helps to drive Á¢²©¹ÙÍø’s reputation as innovation and entrepreneurship hub.”
was awarded the LSQ McCullough Robertson Industry Excellence Award in recognition of his significant contribution to the Á¢²©¹ÙÍø life sciences industry over his 30-year career.
Dr Smythe was involved in the discovery and translation of the anti-flu drug Relenza. In 2022, he became the CEO of , a start-up company leading the development of first-in-class pharmaceuticals to treat cardiovascular disease.
was awarded the Rose-Anne Kelso Commemorative Award for her research focused on improving cardiovascular health in under-represented communities including women and people from culturally and linguistically diverse communities.
Dr Shah is the fourth UQ researcher in a row to win the Rose-Anne Kelso Award.
Other UQ finalists in the 2023 LSQ awards included , and .
Media: UQ Communications, communications@uq.edu.au; +61 429 056 139
